Parasite sheds light on sleeping sickness

Fresh insight into the survival strategy of the sleeping sickness parasite could help inform treatments for the disease.

University scientists have found that the parasite, which can transform itself into either of two physical forms, has developed a careful balance between these.

One of these types ensures infection in the bloodstream of a victim, and the other type is taken up by the tsetse fly and spread to another person or animal.

Balanced approach

The parasite maintains a trade-off between maintaining enough to beat off the and cause infection, and ensuring sufficient parasites to enable the spread of the disease.

Researchers used a combination of biological and mathematical techniques to show how the parasite balances production of each of the forms.

Their results enable fresh understanding of how the parasite reacts to its surroundings to ensure its survival in the short term as well as the long-term spread of the disease.

Millions at risk

Sleeping sickness, which is spread by the bite of the tsetse fly, affects some 30,000 people in sub-Saharan Africa. Many millions more are considered to be at risk.

The disease affects people and animals and without treatment is considered fatal.

The research, funded by the Wellcome Trust, was published in the journal .

" parasites alter their form in order to ensure their survival and spread. We hope that, having discovered more about how these parasites behave, we will be able to develop ways of interfering with their survival strategy and interrupt the spread of this disease," said Professor Keith Matthews, School of Biological Sciences.

Provided by University of Edinburgh

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Revealing secrets of 'African sleeping sickness'

Oct 27, 2008

Scientists in the United Kingdom and Russia are reporting identification of a long-sought chink in the armor of the parasite that causes African sleeping sickness, a parasitic disease that kills at least 50,000 people each ...

Recommended for you

Ebola vaccine promising in first human trials

4 hours ago

Researchers say they are one step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

At one month, US Ebola monitors finding no cases

7 hours ago

The U.S. program that requires weeks of monitoring for travelers from African countries with Ebola reaches the one-month mark Thursday. And so far, no cases of the disease have turned up.

EU calls for 5,000 doctors to fight Ebola

7 hours ago

The European Commission called for 5,000 doctors to be sent from EU states to combat west Africa's Ebola epidemic, a European source with knowledge of the matter said on Wednesday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.